Corrigendum to “Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs” [Clin. Mass Spectrom. 14(Part A) (2019) 34–45]

por Kuhlin, Johanna, Sturkenboom, Marieke G.G., Ghimire, Samiksha, Margineanu, Ioana, van den Elsen, Simone H.J., Simbar, Noviana, Akkerman, Onno W., Jongedijk, Erwin M., Koster, Remco A., Bruchfeld, Judith, Touw, Daan J., Alffenaar, Jan-Willem C.
Publicado 2022

Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a pros...

por van den Elsen, Simone HJ, Sturkenboom, Marieke GG, Akkerman, Onno, Barkane, Linda, Bruchfeld, Judith, Eather, Geoffrey, Heysell, Scott K, Hurevich, Henadz, Kuksa, Liga, Kunst, Heinke, Kuhlin, Johanna, Manika, Katerina, Moschos, Charalampos, Mpagama, Stellah G, Muñoz Torrico, Marcela, Skrahina, Alena, Sotgiu, Giovanni, Tadolini, Marina, Tiberi, Simon, Volpato, Francesca, van der Werf, Tjip S, Wilson, Malcolm R, Zúñiga, Joaquin, Touw, Daan J, Migliori, Giovanni B, Alffenaar, Jan-Willem
Publicado 2020